Key result
Cardiac contractility modulation increases LVEF by ~10% versus sham in dogs with chronic heart failure.
Why the study?
Acute studies showed cardiac contractility modulation improved LV function without increasing oxygen consumption, but the effects of long-term delivery on LV function and remodeling remained to be examined.
Does cardiac contractility modulation improve left ventricular function and remodeling in dogs with chronic heart failure?
Population
Dogs with intracoronary microembolization-induced chronic HF (including 19 dogs in a second study)
Comparison
CCM monotherapy vs sham, and MET-ER plus CCM vs MET-ER monotherapy vs no therapy
Design
Randomized controlled animal study
Follow-up
3 months
Authors
Loading...
CCM improves LV function in canine HF; leaves open translation to patients pending clinical trials.
RCT
Randomized
Does cardiac contractility modulation improve left ventricular function and remodeling in dogs with chronic heart failure?
Absolute Event Rate: 33% vs 23%
p-value: p=< 0.0001
Long-term cardiac contractility modulation therapy improves LV systolic function and reverses remodeling in a canine model of heart failure, with additive benefits when combined with beta-blockers.
Imai et al. (2007) conducted an RCT in Chronic heart failure (HF). Cardiac contractility modulation (CCM) vs. Sham-operated control or no therapy was evaluated on Left ventricular ejection fraction (EF) (p=< 0.0001). In dogs with chronic heart failure, 3 months of cardiac contractility modulation increased left ventricular ejection fraction to 33% compared to a decrease to 23% in sham-operated controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: